New implant could help fight opioid addiction – first safety tests underway
Disease control
Recruiting now
This early-stage study is testing the safety of a nalmefene implant in 24 healthy adults. Nalmefene is a drug that blocks opioid effects, and the implant slowly releases it over weeks. The goal is to see if the implant is safe and how the drug moves through the body, which will g…
Phase: PHASE1 • Sponsor: ReacX Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 05, 2026 11:53 UTC